Skip to content

Study of Gut Microbial Metabolites in Sepsis Patients

Study of Gut Microbial Metabolites in Sepsis Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113369
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Healthy control group:NA

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Sepsis patients Age 18–80 years. 2. Fulfillment of Sepsis-3 criteria: suspected or documented infection AND Sequential Organ Failure Assessment (SOFA) score >= 2. 1. Healthy controls Sex- and age-matched to enrolled sepsis patients. 2. No evidence of sepsis.

Exclusion criteria

Exclusion criteria: 1.Patients with advanced/metastatic cancer; 2. Patients who have undergone colostomy or ileostomy; 3. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Intestinal microbiome metabolomics;

Countries

China

Contacts

Public ContactYong Luan

The First Affiliated Hospital of Dalian Medical University

luanyong@firsthosp-dmu.com+86 18098876221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026